Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8815901 Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors

Patent 8815901 was granted and assigned to Novartis on August, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 5 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 5 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11998545 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
0
Edits on 24 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11964988 Fused heterocyclic compounds as RET kinase inhibitors
0
Edits on 27 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11851434 Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors
0
Edits on 22 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 22 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 08815901 Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors US Patent 8815901 Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors

Infobox
Patent Number
0881590100
Patent Number
881590100
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0881590100
Edits on 23 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Novartis
Novartis
0
Current Assignee
Novartis
Novartis
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
088159010
Date of Patent
August 26, 2014
0
Patent Application Number
139625420
Date Filed
August 8, 2013
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=088159010
Patent Primary Examiner
‌
Douglas M Willis
0
Edits on 28 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Novartis
Novartis
0
Current Assignee
Novartis
Novartis
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
088159010
Date of Patent
August 26, 2014
0
Patent Application Number
139625420
Date Filed
August 8, 2013
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=088159010
Patent Primary Examiner
‌
Douglas M Willis
0
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=08815901
Edits on 24 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 24 Dec, 2021
Edits made to:
Infobox (+9 properties)
‌

 US Patent 08815901 Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors

Infobox
Is a
Patent
Patent
Patent applicant
Novartis
Novartis
Current assignee
Novartis
Novartis
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
08815901
Date of patent
August 26, 2014
Patent application number
13962542
Date Filed
August 8, 2013
Patent primary examiner
‌
Douglas M Willis

Find more entities like US Patent 8815901 Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo